Zobrazeno 1 - 10
of 1 094
pro vyhledávání: '"Zirlik, K."'
Autor:
Schlosser P; Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg, Freiburg, Germany., Schiwitza A; Hematology/Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Klaus J; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany., Hieke-Schulz S; Institute of Medical Biometry and Medical Informatics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.; Roche Pharma AG, Grenzach-Wyhlen, Germany., Szic KSV; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany., Duyster J; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany., Trepel M; Hematology/Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Zirlik K; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany.; Tumor- Und BrustZentrum Ostschweiz, Chur, Switzerland., Schumacher M; Institute of Medical Biometry and Medical Informatics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany., Claus R; Hematology/Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. rainer.claus@uk-augsburg.de.; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany. rainer.claus@uk-augsburg.de.; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. rainer.claus@uk-augsburg.de.; Faculty of Medicine, Comprehensive Cancer Center, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany. rainer.claus@uk-augsburg.de.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 May; Vol. 103 (5), pp. 1613-1622. Date of Electronic Publication: 2024 Feb 03.
Autor:
Quinten E; Department of Hematology, Leiden University Medical Center, Leiden., Sepúlveda-Yáñez JH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands; School of Medicine, Universidad de Magallanes, Punta Arenas, Chile., Koning MT; Department of Hematology, Leiden University Medical Center, Leiden., Eken JA; Department of Hematology, Leiden University Medical Center, Leiden., Pfeifer D; Department of Medicine I, University Medical Center Freiburg, Freiburg., Nteleah V; Department of Hematology, Leiden University Medical Center, Leiden., De Groen RAL; Department of Hematology, Leiden University Medical Center, Leiden., Saravia DA; School of Medicine, Universidad de Magallanes, Punta Arenas, Chile., Knijnenburg J; Department of Clinical Genetics, Leiden University Medical Center, Leiden., Stuivenberg-Bleijswijk HE; Department of Hematology, Leiden University Medical Center, Leiden., Pantic M; Department of Medicine I, University Medical Center Freiburg, Freiburg., Agathangelidis A; Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Keppler-Hafkemeyer A; Department of Medicine I, University Medical Center Freiburg, Freiburg., Van Bergen CAM; Department of Hematology, Leiden University Medical Center, Leiden., Uribe-Paredes R; Department of Computer Engineering, Universidad de Magallanes, Punta Arenas, Chile; Centre for Biotechnology and Bioengineering, Santiago, Chile., Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden., Zirlik K; Department of Medicine I, University Medical Center Freiburg, Freiburg, Germany; Tumor-und Brustzentrum Ostschweiz, Chur., Navarrete MA; School of Medicine, Universidad de Magallanes, Punta Arenas, Chile., Jumaa H; Institute of Immunology, University of Ulm, Ulm., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden. j.h.veelken@lumc.nl.
Publikováno v:
Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 824-834. Date of Electronic Publication: 2024 Mar 01.
Publikováno v:
Leukemia (08876924). Aug2015, Vol. 29 Issue 8, p1763-1770. 8p. 6 Graphs.
Autor:
Leonhardt, F1, Zirlik, K2, Buchner, M3, Prinz, G2, Hechinger, A-K1, Gerlach, U V4, Fisch, P4, Schmitt-Gräff, A4, Reichardt, W5, Zeiser, R2
Publikováno v:
Leukemia (08876924). Jul2012, Vol. 26 Issue 7, p1617-1629. 13p. 7 Graphs.
Autor:
Alfaifi, Abdullah1,2,3 (AUTHOR), Bahashwan, Salem3,4,5 (AUTHOR), Alsaadi, Mohammed3 (AUTHOR), Ageel, Ali H.6 (AUTHOR), Ahmed, Hamzah H.7 (AUTHOR), Fatima, Kaneez8 (AUTHOR), Malhan, Hafiz9 (AUTHOR), Qadri, Ishtiaq1 (AUTHOR), Almehdar, Hussein1 (AUTHOR) hmehdar@kau.edu.sa, Kumar, Manishekhar (AUTHOR)
Publikováno v:
Advances in Hematology. 11/11/2024, Vol. 2024, p1-22. 22p.
Autor:
Enemark, Marie Hairing1,2 (AUTHOR) mariem@rm.dk, Hemmingsen, Jonas Klejs1 (AUTHOR) johemm@rm.dk, Jensen, Maja Lund1 (AUTHOR) majalj@rm.dk, Kridel, Robert3 (AUTHOR) robert.kridel@uhn.ca, Ludvigsen, Maja1,2 (AUTHOR) majlud@rm.dk
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11179. 52p.
Autor:
Korbecki, Jan1,2 (AUTHOR) jan.korbecki@onet.eu, Bosiacki, Mateusz2 (AUTHOR), Stasiak, Piotr1 (AUTHOR) p.stasiak@inz.uz.zgora.pl, Snarski, Emilian3 (AUTHOR) emiliansnarski@gmail.com, Brodowska, Agnieszka4 (AUTHOR) agnieszka.brodowska@pum.edu.pl, Chlubek, Dariusz2 (AUTHOR), Baranowska-Bosiacka, Irena2 (AUTHOR) irena.baranowska.bosiacka@pum.edu.pl
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 19, p3246. 29p.
Publikováno v:
132. Kongress der Deutschen Gesellschaft für Chirurgie; 20150428-20150501; München; DOC15dgch093 /20150424/
Einleitung: Die Kombination aus perioperativer Chemotherapie und chirurgischer Resektion hat sich zum Therapiestandard lokal fortgeschrittener Adenokarzinome des Magens und des gastroesophagealen Übergangs (EGAC) entwickelt. Bei 30 - 50 % der therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c99c7a11900c9f063cc4477f747d948
Publikováno v:
Immunology, 137, 163-163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d1301d0048e05bf7a42afcdcd88fae80
https://hdl.handle.net/1887/97312
https://hdl.handle.net/1887/97312